| Application no. and date | 11716429.3 (espacenet) (Federated) (European Patent Register), 20110429 | | Patent/reg. no. and date | DK/EP 2563400, 20190710 | | Publication date | 20130306 | | Priority no. and date | EP 10161685, 20100430 | | EP pub. no. and date |
EP 2563400 20130306 | | Effective date | | | Applicant/owner | Molecular Partners AG, Wagistrasse 14
8952 Schlieren, CH | | Applicant ref. no. | BBS130765EPDK | | Inventor | Binz, Hans Kaspar,
Bachstrasse 27
8903 Birmensdorf, CH,
FORRER, Patrik, Rainackerstrasse 17
8953 Dietikon, CH,
STUMPP, Michael Tobias, Chratzstrasse 6
8954 Geroldswil, CH | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 47/60 (2017.01) , A61P 27/02 (2006.01) , A61P 35/00 (2006.01) , C07K 14/47 (2006.01) | | Title | Modificerede bindeproteiner, der hæmmer VEGF-A-receptorinteraktion | | Int. application no. | EP2011056824 | | Int. publication no. | WO2011135067 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
